BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19155313)

  • 1. Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice.
    Ecke I; Petry F; Rosenberger A; Tauber S; Mönkemeyer S; Hess I; Dullin C; Kimmina S; Pirngruber J; Johnsen SA; Uhmann A; Nitzki F; Wojnowski L; Schulz-Schaeffer W; Witt O; Hahn H
    Cancer Res; 2009 Feb; 69(3):887-95. PubMed ID: 19155313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.
    Nitzki F; Tolosa EJ; Cuvelier N; Frommhold A; Salinas-Riester G; Johnsen SA; Fernandez-Zapico ME; Hahn H
    Oncotarget; 2015 Apr; 6(11):9113-24. PubMed ID: 25823816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
    Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
    Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
    Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
    Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-point and dosage of gene inactivation determine the tumor spectrum in conditional Ptch knockouts.
    Zibat A; Uhmann A; Nitzki F; Wijgerde M; Frommhold A; Heller T; Armstrong V; Wojnowski L; Quintanilla-Martinez L; Reifenberger J; Schulz-Schaeffer W; Hahn H
    Carcinogenesis; 2009 Jun; 30(6):918-26. PubMed ID: 19321799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
    Patties I; Kortmann RD; Menzel F; Glasow A
    J Exp Clin Cancer Res; 2016 Jun; 35(1):94. PubMed ID: 27317342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of a silenced H19 gene in human rhabdomyosarcoma by demethylation of DNA but not by histone hyperacetylation.
    Lynch CA; Tycko B; Bestor TH; Walsh CP
    Mol Cancer; 2002 Jul; 1():2. PubMed ID: 12234381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid, in combination with all-trans retinoic acid and 5-aza-2'-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells.
    Mongan NP; Gudas LJ
    Mol Cancer Ther; 2005 Mar; 4(3):477-86. PubMed ID: 15767557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
    Luszczek W; Cheriyath V; Mekhail TM; Borden EC
    Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.
    Yan L; Nass SJ; Smith D; Nelson WG; Herman JG; Davidson NE
    Cancer Biol Ther; 2003; 2(5):552-6. PubMed ID: 14614325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A; Santini V
    Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbalanced overexpression of the mutant allele in murine Patched mutants.
    Calzada-Wack J; Kappler R; Schnitzbauer U; Richter T; Nathrath M; Rosemann M; Wagner SN; Hein R; Hahn H
    Carcinogenesis; 2002 May; 23(5):727-33. PubMed ID: 12016144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms.
    Gore SD; Baylin S; Sugar E; Carraway H; Miller CB; Carducci M; Grever M; Galm O; Dauses T; Karp JE; Rudek MA; Zhao M; Smith BD; Manning J; Jiemjit A; Dover G; Mays A; Zwiebel J; Murgo A; Weng LJ; Herman JG
    Cancer Res; 2006 Jun; 66(12):6361-9. PubMed ID: 16778214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.
    Hahn H; Wojnowski L; Specht K; Kappler R; Calzada-Wack J; Potter D; Zimmer A; Müller U; Samson E; Quintanilla-Martinez L; Zimmer A
    J Biol Chem; 2000 Sep; 275(37):28341-4. PubMed ID: 10884376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
    Meng CF; Zhu XJ; Peng G; Dai DQ
    Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
    Yuan J; Llamas Luceño N; Sander B; Golas MM
    Cell Oncol (Dordr); 2017 Jun; 40(3):263-279. PubMed ID: 28429280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo.
    Steele N; Finn P; Brown R; Plumb JA
    Br J Cancer; 2009 Mar; 100(5):758-63. PubMed ID: 19259094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of NY-ESO-1 antigen expression by a novel histone deacetylase inhibitor, valproic acid, with 5-aza-2'-deoxycytidine in glioma cells.
    Oi S; Natsume A; Ito M; Kondo Y; Shimato S; Maeda Y; Saito K; Wakabayashi T
    J Neurooncol; 2009 Mar; 92(1):15-22. PubMed ID: 19030781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the PTCH coding region in human rhabdomyosarcoma.
    Calzada-Wack J; Schnitzbauer U; Walch A; Wurster KH; Kappler R; Nathrath M; Hahn H
    Hum Mutat; 2002 Sep; 20(3):233-4. PubMed ID: 12204003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.
    Venza I; Visalli M; Fortunato C; Ruggeri M; Ratone S; Caffo M; Caruso G; Alafaci C; Tomasello F; Teti D; Venza M
    Epigenetics; 2012 Nov; 7(11):1315-30. PubMed ID: 23051921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.